This first semester was rich in news for the French subsidiary of the Chiesi laboratory, notably with the marketing of a new drug specializing in severe COPD.
While waiting to meet you at the start of September with many events, we wish you all an excellent summer vacation.
However, if you have an idea or a digital project to share that could improve the lives of patients with respiratory problems, log on to: https://www.respirhacktion.com/
Chiesi, will support the 3rd edition of RespirH@cktion composed of a team of 10 Chiesi employees in order to advance patient projects!
